- Lobbying
- Lobbying by Charlotte's Web, Inc.
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Arshi Siddiqui | Sr pol adv & cnsl for Spkr Pelosi, Oct 03-May 09; Ways & Means cnsl, Rep Becerra, 1998-May 00; pol aide, Rep Clayton, Oct 97-Jan 98 |
Brendan Dunn | Staff Mbr and Leg Asst to Sen Hatch Judiciary Comm and Sub-Comm, Apr04-May07, Aug07-May08; Special Counsel to Sen Hatch Fin Comm, Jan 11-Dec 12; Policy Adv and Counsel to Sen McConnell Majority Leader staff, Dec 12-May18. |
Louis Agnello | Snr Cnsl, Joint Econ Committee, Mar 17-Nov 17; Leg cnsl, Sen Heinrich, Apr 14-Mar 17; Leg Asst, Rep Doris Matsui, Dec 11-Apr 14; Leg Asst, Senate Judiciary Committee, May 09-Aug 09; Research Analyst, Senate Small Business Committee, Jun 07-Aug 08 |
John Gilliland | Intl trade cnsl, S Fin Comm, Feb 03-Jan 05; leg asst to Sen Lincoln, Jun 01-Feb 03 |
Hans Rickhoff | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q2 Report
Q1 Report
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues
Registration
Issue(s) they said they’d lobby about: Federal policy related to cannabinoids with CBD extract..
Registration
Issue(s) they said they’d lobby about: Federal policy related to cannabinoids with CBD extract..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate